New therapies for atopic dermatitis: Additional treatment classes
- 1 March 2018
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 78 (3), S76-S83
- https://doi.org/10.1016/j.jaad.2017.12.024
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Coal tar induces AHR-dependent skin barrier repair in atopic dermatitisJCI Insight, 2013
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitisJournal of Allergy and Clinical Immunology, 2012
- Abnormal epidermal barrier in the pathogenesis of contact dermatitisClinics in Dermatology, 2012
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic conceptsJournal of Allergy and Clinical Immunology, 2011
- Targeted treatment of pruritus: a look into the futureBritish Journal of Dermatology, 2011
- Antipruritic treatment with systemic μ-opioid receptor antagonists: A reviewJournal of the American Academy of Dermatology, 2010
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cellsJournal of Allergy and Clinical Immunology, 2009
- Effects of Atypical κ-Opioid Receptor Agonists on Intrathecal Morphine-Induced Itch and Analgesia in PrimatesThe Journal of pharmacology and experimental therapeutics, 2008
- Antimicrobial Peptides, Skin Infections, and Atopic DermatitisSeminars in Cutaneous Medicine and Surgery, 2008
- Plasma levels of polyunsaturated fatty acids in children with atopic dermatitis and in atopic and nonatopic controlsWiener klinische Wochenschrift, 2005